Franklin Biotechnology Discovery Fund

Portfolio Statistics

Assets

Total Fund AssetsAs of 03/31/2020 (updated monthly) $1,018.1 (M)
Net Assets - Class C As of 02/29/2020 (updated monthly) $45.6 (M)

Positions As of 03/31/2020

Equity VS. NASDAQ Biotechnology Index

Fund Benchmark
Market CapitalizationAs of 03/31/2020 (updated monthly) $31,964.32(M) $38,253.63(M)
P/B RatioAs of 03/31/2020 (updated monthly) 5.19 4.46
P/E Ratio (12-mo Forward)As of 02/29/2020 (updated monthly) 14.97 14.64
Price to Cash FlowAs of 03/31/2020 (updated monthly) 16.81 13.42

Portfolio Details

Asset AllocationAs of 03/31/2020

[name] [value]
Equity 92.93%
Cash & Cash Equivalents 7.07%

Geographic BreakdownAs of 03/31/2020

No chart available for this data.
[name] [value]
United States 80.67%
Cash & Cash Equivalents 7.07%
United Kingdom 3.76%
Netherlands 3.03%
Denmark 2.34%
Canada 1.75%
Switzerland 0.69%
Germany 0.60%
Ireland 0.08%

sector breakdownAs of 02/29/2020

[name] [value]
Biotechnology 79.56%
Pharmaceuticals 12.20%
Life Sciences Tools & Services 4.13%
Cash & Cash Equivalents 4.11%

TOP TEN HOLDINGSAs of 03/31/2020

Issuer Country Industry % of total
VERTEX PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 7.94%
BIOGEN INC United States Pharmaceuticals, Biotechnology & Life Sciences 6.77%
AMGEN INC United States Pharmaceuticals, Biotechnology & Life Sciences 6.35%
GILEAD SCIENCES INC United States Pharmaceuticals, Biotechnology & Life Sciences 6.30%
REGENERON PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 6.14%
ILLUMINA INC United States Pharmaceuticals, Biotechnology & Life Sciences 4.72%
IOVANCE BIOTHERAPEUTICS INC United States Pharmaceuticals, Biotechnology & Life Sciences 4.17%
GW PHARMACEUTICALS PLC United Kingdom Pharmaceuticals, Biotechnology & Life Sciences 3.63%
PTC THERAPEUTICS INC United States Pharmaceuticals, Biotechnology & Life Sciences 3.30%
REATA PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 2.47%

Market Capitalization BreakdownAs of 03/31/2020

[name] [value]
<2.0 Billion 20.14%
2.0-5.0 Billion 24.15%
5.0-10.0 Billion 9.92%
10.0-25.0 Billion 4.34%
25.0-50.0 Billion 5.08%
>50.0 Billion 36.04%
N/A 0.34%